• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

10,015
2,295
1,799
1,792
1,739

COUNTRY

808
620
258
244
227

CATEGORIES

  • 718
  • 150
  • 951
  • 1,082
    • 108
  • 355
  • 252
  • 200
  • 64
  • 372
  • 634
  • 1,026
  • 1,615
  • 625
  • 869
  • 1,564
  • 2,448
    • 576
    • 122
    • 558
    • 80
    • 530
    • 43
    • 507
    • 17
    • 19
    • 25
  • 505
  • 704
  • 0
  • 135

PRICE

5,756
10,329
15,043
22,836

PUBLISHED

1,590
2,354
6,646
22,836

PRODUCT TYPE

18,446
3,187
862
142
73
46
24
21
21
8
6

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Calming and Sleeping in Uzbekistan Calming and Sleeping in Uzbekistan - Product Thumbnail Image

Calming and Sleeping in Uzbekistan

Towards the end of the review period, the use of calming and sleeping products continued to be stimulated by the increasingly hectic lifestyles of Uzbeks, combined with increased awareness of the damage...

April 2013
FROM
Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan - Product Thumbnail Image

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan

Sales of cough, cold and allergy remedies increased by 12% in current value terms in Uzbekistan in 2012. Despite years of healthy development, aided by consumers’ increased awareness of self-medication,...

April 2013
FROM
Digestive Remedies in Uzbekistan Digestive Remedies in Uzbekistan - Product Thumbnail Image

Digestive Remedies in Uzbekistan

Stressful and time-pressured lifestyles gave rise to growing demand for digestive remedies in Uzbekistan. The category continued to record double-digit growth in 2012, increasing by 22% in current value...

April 2013
FROM
Vitamins and Dietary Supplements in Uzbekistan Vitamins and Dietary Supplements in Uzbekistan - Product Thumbnail Image

Vitamins and Dietary Supplements in Uzbekistan

Towards the end of the review period, vitamins and dietary supplements remained popular in Uzbekistan. In the minds of Uzbeks, these products are gradually being considered as one of the best ways of...

April 2013
FROM
Depilatories in China Depilatories in China - Product Thumbnail Image

Depilatories in China

Depilatories witnessed current value growth of 6% in 2012, down from 10% growth in 2011. The significant slowdown in growth can be attributed to gloomy economic development and decelerating economic...

April 2013
FROM
Depilatories in Finland Depilatories in Finland - Product Thumbnail Image

Depilatories in Finland

Depilatories current retail value sales declined by 2% to €6.5 million in 2012. As the economic downturn became more severe, Finnish consumers became more careful with their spending and limited and...

April 2013
FROM
Pharmacogenomics Pharmacogenomics - Product Thumbnail Image

Pharmacogenomics

Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation includes discussions and viewpoints from the academic, regulatory, pharmaceutical, clinical, socio-ethical and economic perspectives....

April 2013

Russia Pharmaceuticals and Healthcare Report Q2 2013

BMI View: Russia's pharmaceutical market continues to be one of the most attractive in the Emerging Europe region, primarily due to its sheer market size, growing economy and increasing government investment...

April 2013

United Kingdom Pharmaceuticals and Healthcare Report Q2 2013

BMI View: We are relatively optimistic about the longer-term performance of the UK's pharmaceutical market, on account of rising demand for services and treatment, stimulated by factors such as an ageing...

April 2013

Belarus Pharmaceuticals and Healthcare Report Q2 2013

BMI View: We expect the volatility in the performance of the Belarusian pharmaceutical market to continue, with political tensions increasing risks to our forecasts Although the government aims to increase...

April 2013

Czech Republic Pharmaceuticals and Healthcare Report Q2 2013

BMI View: The Czech pharmaceutical market is the most developed in terms of spending and ease of operation in the Central and Eastern European region, but it continues to present challenges for drugmakers...

April 2013

Indonesia Pharmaceuticals and Healthcare Report Q2 2013

BMI View: Commercial interest in Indonesia's healthcare sector will accelerate over the course of 2014, the year that marks the introduction of universal health insurance The programme is expected to...

April 2013

Kenya Pharmaceuticals and Healthcare Report Q3 2013

BMI View: Kenya is an attractive prospect for companies looking to set up a manufacturing base in the region. Among the East African Community (EAC), Kenya has the deepest financial markets and an...

April 2013

Lithuania Pharmaceuticals and Healthcare Report Q2 2013

BMI View: We expect the Lithuanian pharmaceutical market to continue to develop steadily over the coming years, on account of demographic and epidemiological factors However, its small population and...

April 2013

Philippines Pharmaceuticals and Healthcare Report Q2 2013

BMI View: Opportunities in the Philippines pharmaceutical and healthcare markets are currently supported by a lack of governance over drug pricing, providing short-term revenue growth opportunities...

April 2013

Puerto Rico Pharmaceuticals and Healthcare Report Q2 2013

BMI View: The importance of Puerto Rico as a major production hub for multinational pharmaceutical companies will continue to deteriorate due to drug patent expiration, production quality issues, increasing...

April 2013

Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017

The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal...

April 2013
FROM
Vitamins and Dietary Supplements in Algeria Vitamins and Dietary Supplements in Algeria - Product Thumbnail Image

Vitamins and Dietary Supplements in Algeria

Vitamins and dietary supplements recorded strong 12% value growth in 2012. The category witnessed stronger consumer demand from all income groups in urban areas. Product developments in 2011 and 2012,...

April 2013
FROM
Digestive Remedies in Algeria Digestive Remedies in Algeria - Product Thumbnail Image

Digestive Remedies in Algeria

Digestive remedies registered strong 13% value growth in 2012 and remained the category showing the most dynamic value performance in overall consumer health. Digestive remedies are essentially purchased...

April 2013
FROM
Calming and Sleeping in Algeria Calming and Sleeping in Algeria - Product Thumbnail Image

Calming and Sleeping in Algeria

Calming and sleeping registered strong 11% value growth in 2012. Strong value growth was due to a higher demand in urban areas where the population experiences a busier and more stressful lifestyle,...

April 2013
FROM
Loading Indicator

Our Clients

Our clients' logos